BioWorld

May 14, 2002

View Archived Issues

Athersys Raises $16.2M Privately To Continue Multiple Programs

Athersys Inc. completed a private placement totaling $16.2 million to be used to continue about a dozen projects, which focus on oncology, the central nervous system and inflammation. (BioWorld Today) Read More

Phylos, Avalon Using PROfusion To Identify Drug-Protein Targets

Read More

Natural Killer Cell Subset Skulks Doggo For Years During HAART Drug Treatment, Then Breaks Out

Read More

Biosynexus Pushing Ahead With Protein-Based Platforms

Read More

Other News To Note

Read More

Quarterly Earnings Reports

Read More